Otherwise, Lan and colleagues demonstrated that genetic polymorphisms of insulin-like growth factor 1 (IGF-1) and interleukin-8 (IL-8) increased susceptibility to lymph node metastasis in CRC patients 27. The gene discussed is IGF1; the disease is metastatic malignant neoplasm in the lymph nodes.